You are here

Gilead cash pile burns hole in investors' pockets

San Francisco

IN THE drug industry's biggest-ever period for deals, one wildly successful company with a multibillion-dollar war chest has been oddly silent. So what's Gilead Sciences Inc waiting for?

Drugmakers have done US$179 billion worth of mergers and acquisitions so far this